Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series
Erythrodermic psoriasis (EP) is a severe and complex form of psoriasis. While risankizumab, an interleukin (IL)-23 inhibitor, has demonstrated efficacy in patients with moderate-to-severe plaque psoriasis, its effectiveness in patients with EP remains less explored. The literature contains several...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
PAGEPress Publications
2025-07-01
|
| 叢編: | Dermatology Reports |
| 主題: | |
| 在線閱讀: | https://www.pagepress.org/journals/dr/article/view/10379 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|